Skip to content

Clinical trials

Observational Tuberculosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis Phase: Observational Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20051
20061
20073
20091
20112
20123
20131
20143
20152
20161
20171
20195
20213
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated4
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)11
QIAGEN Gaithersburg, Inc4
Centers for Disease Control and Prevention2
Johns Hopkins University2
Oxford Immunotec2
BioMérieux1
Cepheid1
Columbia University1
M.D. Anderson Cancer Center1
NYU Langone Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis32
Latent Tuberculosis4
Mycobacterium Infections3
Extensively Drug-Resistant Tuberculosis2
HIV Infections2
AIDS-Related Opportunistic Infections1
Acquired Immunodeficiency Syndrome1
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Communicable Diseases1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.